Notably, few reports have explored the role of the albumin‐to‐fibrinogen ratio (AFR) in HNSCC, though the value of AFR as a prognostic indicator has been evaluated in patients with hepatocellular carcinoma [42], colorectal cancer [43], and gastric cancer [44]. This evidence concerns the gene ALB and head and neck squamous cell carcinoma.